VisionSys AI Inc

VisionSys AI Inc. has issued a notice for its General Meeting of Shareholders to be held on June 26, 2026. Key proposals include increasing the authorized share capital to US$260,000,000, adopting a new memorandum and articles of association, and designating the meeting as the annual general meeting while ratifying the 2025 financial statements. The meeting will also address changes related to voting rights of Class B shares, conversion rights of Class A shares, scripless shares, and a potential company name change.

VisionSys AI Inc announced plans to change its American depositary shares (ADSs) ratio, effective around May 26, 2026. The ratio will shift from 1 ADS representing 250 Class A ordinary shares to 1 ADS representing 2,500 Class A ordinary shares, which is equivalent to a one-for-ten reverse ADS split. Existing ADS holders will have their shares automatically exchanged, with no action required on their part, and fractional entitlements will be sold for cash distribution.

VisionSys AI Inc. announced it is in advanced discussions with a strategic investor for a proposed $90 million investment at $1.50 per share. This investment aims to support the company's focus on advancing its Brain-Computer Interface (BCI) business and accelerating AI-powered healthcare and biotechnology solutions. The proceeds are planned for R&D, product commercialization, global expansion, and working capital, enhancing VSA's liquidity and financial flexibility.